Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection
Journal of Ocular Pharmacology and Therapeutics · 2024
DOI: 10.1089/jop.2024.0071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2024. Verfasst von Asad F Durrani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Chlorhexidine, Intravitreal Injections, Drug Stability, Cost-Benefit Analysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Purpose
Commercially available chlorhexidine gluconate (CHG) has a beyond-use date of 24 h. This study evaluated the stability and sterility of 0.05% CHG for 30 days after opening and compared its cost to povidone iodine (PI) for intravitreal injection antisepsis.
Methods
0.05% CHG was aliquoted into 1-mL syringes and stored at room temperature or refrigerated. Turbidity, pH, high-performance liquid chromatography (HPLC), and sterility testing were performed. A cost analysis was conducted.
Results
0.05% CHG remained stable for at least 30 days. All samples had measured turbidity
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Department of Pharmaceutical Sciences, Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Alberta Retina Consultants and the University of Alberta, Edmonton, Canada.
- Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.
ORCID-Profile: Asad F Durrani
Förderung
- NIGMS NIH HHS
Zitieren
APA
Durrani, A. F., Momenaei, B., Soni, V., Tennant, M., Hsu, J., Vander, J., Spirn, M., Kang, E. Y., Hwang, Y. S., Kaushal, G., & Garg, S. J. (2024). Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2024.0071
Vancouver
Durrani AF, Momenaei B, Soni V, Tennant M, Hsu J, Vander J, et al. Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection. Journal of Ocular Pharmacology and Therapeutics. 2024. doi:10.1089/jop.2024.0071
BibTeX
@article{Durrani2024,
author = {Durrani, Asad F and Momenaei, Bita and Soni, Viren and Tennant, Matthew and Hsu, Jason and Vander, James and Spirn, Marc and Kang, Eugene Yu-Chuan and Hwang, Yih-Shiou and Kaushal, Gagan and Garg, Sunir J},
title = {Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2024},
doi = {10.1089/jop.2024.0071}
}
EUVIMED